• Neuromedin S (rat): Technical Parameters and Workflow Guidan

  2026-05-06

  Neuromedin S (rat) is a chemically defined peptide agonist for precise activation of neuromedin U receptor signaling in controlled GPCR/G protein workflows. It is intended strictly for research applications such as assays investigating energy homeostasis regulation and stress response in rat models, and is not suitable for diagnostic or medical purposes.

• Y-27632 Dihydrochloride: Applied Protocols in Organoid and C

  2026-05-05

  Y-27632 dihydrochloride, a highly selective ROCK inhibitor, streamlines experimental workflows in organoid, stem cell, and cancer research. This article translates contemporary protocols and reference findings into actionable strategies, including troubleshooting and advanced optimization, for researchers seeking robust cytoskeletal and viability outcomes.

• Ferritin-Based Hybrid Vaccine: M2e and SARS-CoV-2 Epitope In

  2026-05-05

  This study demonstrates a novel vaccine strategy using ferritin-based hybrid protein particles to co-display influenza A M2e and SARS-CoV-2 spike protein epitopes. The approach yields superior immunogenicity and functional antibody responses, underscoring ferritin's potential in efficient combination vaccine development.

• Estradiol Benzoate: Precision Tools for Next-Gen Estrogen Re

  2026-05-04

  This article offers an advanced synthesis of mechanistic insights and actionable strategies for translational researchers leveraging Estradiol Benzoate as a high-affinity estrogen receptor alpha agonist. Integrating evidence from competitive landscapes and protocol parameters, it explores experimental optimization, addresses reproducibility challenges, and positions APExBIO’s offering as a workflow-driven solution for estrogen receptor signaling research.

• Yeast-Based mTOR Inhibitor Screening: Discovery System Advan

  2026-05-04

  This study introduces a highly sensitive yeast-based platform for identifying mTOR/TOR inhibitors, leveraging drug-sensitized strains to dramatically improve detection limits. The findings refine TOR pathway inhibitor discovery and clarify that Canagliflozin does not exhibit TOR-inhibitory activity in this model, guiding future metabolic research assay design.

• ABT-263 (Navitoclax): Technical Guidance for Apoptosis Assay

  2026-05-03

  ABT-263 (Navitoclax) is a selective, orally bioavailable Bcl-2 family inhibitor that enables researchers to dissect apoptotic pathways and assess antitumor responses in oncology models. This compound is best suited for apoptosis assay development and mechanistic studies in cancer biology, but is not intended for diagnostic or therapeutic use. Its utility is limited to research workflows where precise Bcl-2 family inhibition and careful solubilization are required.

• Applied Use-Cases of 3-Deazaneplanocin (DZNep) in Cancer Res

  2026-05-02

  3-Deazaneplanocin (DZNep) stands out as an epigenetic modulator that enables precise control over cancer stem cell targeting and apoptosis induction in AML and HCC models. This guide translates advanced research and validated workflows into actionable protocols, troubleshooting strategies, and comparative insights for reproducible cancer and metabolic disease studies.

• Acetoacetic acid sodium salt: Benchmarks in Ketone Body Rese

  2026-05-02

  Acetoacetic acid sodium salt (sodium 3-oxobutanoate) is a validated ketone body research compound central to studies of fatty acid catabolism and diabetic metabolic imbalance. Its high aqueous solubility, assay reproducibility, and APExBIO’s 98% purity standard enable consistent results in energy metabolism research.

• NUAK1-Mediated Tau Ser356 Phosphorylation in Alzheimer’s Dis

  2026-05-01

  This study demonstrates that phosphorylation of tau protein at Ser356, mediated by NUAK1 kinase, is closely associated with the progression of Alzheimer’s disease pathology. The authors show that selective NUAK inhibition with WZ4003 reduces pathogenic p-tau Ser356 in human brain slice cultures, providing mechanistic insights relevant for future therapeutic strategies.

• Tin Mesoporphyrin IX: Precision Inhibition in Heme Oxygenase

  2026-04-30

  Tin Mesoporphyrin IX (chloride) empowers researchers with nanomolar, reproducible heme oxygenase inhibition, streamlining both metabolic and virology workflows. This article delivers actionable protocols, advanced troubleshooting, and contextualizes the compound’s role in dissecting heme catabolism within metabolic disease and HBV research.

• Capsaicin (E)-Capsaicin: Precision Modulation of TRPV1 and K

  2026-04-30

  Explore how Capsaicin enables precise modulation of TRPV1 ion channels and KDM1A/LSD1 in advanced pain and cancer research. This article uniquely integrates mechanistic insight from chronic dermatitis models with practical protocol guidance for translational assay design.

• Radiopathomics Predicts Immunotherapy Response in Gastric Ca

  2026-04-29

  This study introduces a multimodal radiopathomics signature (RPS) that integrates computed tomography and digital pathology data to predict immunotherapy-based combination therapy response in gastric cancer. The RPS significantly outperforms traditional biomarkers and offers new potential for patient stratification and personalized oncology.

• β-Amanitin: Mechanism and Research Uses in Transcriptional S

  2026-04-29

  β-Amanitin is a potent inhibitor of RNA polymerase II, widely used in transcriptional regulation research. This article provides a detailed, evidence-based overview of its mechanism, benchmarks, and safe laboratory use for mRNA synthesis inhibition assays.

• BAPTA-AM: Cell-Permeable Calcium Chelator for Precision Assa

  2026-04-28

  BAPTA-AM stands out as a versatile cell-permeable calcium chelator, enabling advanced control of intracellular calcium for apoptosis, neuroprotection, and signaling studies. Its dual roles in calcium chelation and potassium channel blocking provide unique advantages for dissecting complex cellular pathways.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Labeling

  2026-04-28

  Cy3 NHS ester (non-sulfonated) offers a robust solution for fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides, particularly where high detection sensitivity and compatibility with standard fluorescence platforms are required. It is ideal for workflows that tolerate organic co-solvents, but not recommended for delicate proteins where water-only labeling is essential.

449 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page